{
    "title": "Pharma giant GSK sees turnover pass \u00a325bn for the year despite being hit by declining sales of key shingles vaccine",
    "url": "https://www.dailymail.co.uk/money/markets/article-8888901/GSK-turnover-passes-25bn-2020-despite-lower-sales-shingles-vaccine.html",
    "date": "2020-10-28",
    "keywords": [
        "cent",
        "drug",
        "vaccine",
        "share",
        "health",
        "gsk",
        "year",
        "maker",
        "month",
        "fund",
        "consumer",
        "end",
        "drop",
        "group",
        "coronavirus",
        "trade",
        "disease",
        "treatment",
        "quarter",
        "trial",
        "walmsley",
        "growth",
        "today",
        "candidate",
        "sanofi",
        "covax",
        "latestage",
        "investment",
        "account",
        "fee",
        "giant",
        "medicine",
        "cash",
        "turnover",
        "healthcare",
        "shingrix",
        "delay",
        "decline",
        "facetoface",
        "tuition",
        "level",
        "lung",
        "trelegy",
        "nucala",
        "jump",
        "oncology",
        "back",
        "cancer",
        "astrazenecas",
        "board",
        "member",
        "time",
        "pharma",
        "boss",
        "ben",
        "arm",
        "article",
        "medication",
        "panadol",
        "voltaren",
        "boost",
        "covid19",
        "pandemic",
        "overthecounter",
        "launch",
        "statesthe",
        "ftse",
        "firm",
        "focus",
        "wellness",
        "performance",
        "centrum",
        "supplement",
        "emergencglaxosmithkline",
        "executive",
        "emma",
        "business",
        "operating",
        "environment",
        "cost",
        "control",
        "momentum",
        "addition",
        "progress",
        "biopharma",
        "forecast",
        "impact",
        "crisis",
        "initiative",
        "bill",
        "melinda",
        "partnership",
        "phase",
        "december",
        "competition",
        "astrazeneca",
        "pfizer",
        "race",
        "antibody",
        "vir7831"
    ],
    "category": [
        "money",
        "markets"
    ]
}